BIT:1ISRG • US46120E6023
The current stock price of 1ISRG.MI is 410.85 EUR. Today 1ISRG.MI is down by -12.25%. In the past month the price decreased by -17.74%.
ChartMill assigns a technical rating of 3 / 10 to 1ISRG.MI.
ChartMill assigns a fundamental rating of 5 / 10 to 1ISRG.MI. 1ISRG.MI gets an excellent profitability rating and is at the same time showing great financial health properties.
On January 22, 2026 1ISRG.MI reported an EPS of 2.53 and a revenue of 2.87B. The company beat EPS expectations (9.85% surprise) and beat revenue expectations (2.22% surprise).
42 analysts have analysed 1ISRG.MI and the average price target is 533.94 EUR. This implies a price increase of 29.96% is expected in the next year compared to the current price of 410.85.
For the next year, analysts expect an EPS growth of 14.46% and a revenue growth 15.92% for 1ISRG.MI
Over the last trailing twelve months 1ISRG.MI reported a non-GAAP Earnings per Share(EPS) of 7.53. The EPS increased by 21.83% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 28.38% | ||
| ROA | 13.96% | ||
| ROE | 16.02% | ||
| Debt/Equity | 0 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 2M6 | MEDTRONIC PLC | 14.75 | 103.215B | ||
| SHL | SIEMENS HEALTHINEERS AG | 15.11 | 45.684B | ||
| 1PHIA | KONINKLIJKE PHILIPS NV | 17.51 | 25.662B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 16.36 | 24.632B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 16.42 | 24.555B | ||
| BIM | BIOMERIEUX | 19.06 | 11.274B | ||
| DIA | DIASORIN SPA | 16.86 | 3.845B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 18.63 | 3.66B | ||
| AFX | CARL ZEISS MEDITEC AG - BR | 10.61 | 2.27B | ||
| DRW3 | DRAEGERWERK AG - PREF | 11.95 | 1.653B | ||
| DRW8 | DRAEGERWERK AG | 9.87 | 1.343B | ||
| ELN | EL.EN. SPA | 21.21 | 1.065B | ||
| EUZ | ECKERT & ZIEGLER SE | 18.11 | 952.165M |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
INTUITIVE SURGICAL INC
1020 Kifer Road
Sunnyvale CALIFORNIA US
Employees: 15638
Phone: 13026587581
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
The current stock price of 1ISRG.MI is 410.85 EUR. The price decreased by -12.25% in the last trading session.
1ISRG.MI does not pay a dividend.
1ISRG.MI has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
INTUITIVE SURGICAL INC (1ISRG.MI) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
The Revenue of INTUITIVE SURGICAL INC (1ISRG.MI) is expected to grow by 15.92% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
You can find the ownership structure of INTUITIVE SURGICAL INC (1ISRG.MI) on the Ownership tab.